Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial

Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial

<p>Abstract</p> <p>Backgrounds</p> <p>Urokinase (UK) 2 200 U/kg·h for 12 hours infusion(UK-12 h)is an ACCP recommended regimen in treating acute pulmonary embolism (PE). It is unclear whether this dose and time can be reduced further. We compared the efficacy and safety...

Full description

Bibliographic Details
Main Authors: Huang Kewu, Dai Huaping, Liang Lirong, Cheng Zhaozhong, Yuan Yadong, Yang Yuanhua, Zhai Zhenguo, Wang Chen, Lu Weixuan, Zhang Zhonghe, Cheng Xiansheng, Shen Ying H
Format: Article
Language:English
Published: BMC 2009-12-01
Series:Respiratory Research
Online Access:http://respiratory-research.com/content/10/1/128

Similar Items

Similar Items